Clinical Trials
4 trialsNCT07002034 2026-05-06
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Reunion Neuroscience Inc
Phase 2 Recruiting
NCT06322342 2025-12-26
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Reveal Pharmaceuticals Inc.
Phase 2 Completed
NCT03944447 2022-06-02
OMNI-Can
OMNI Medical Services, LLC
Phase 2 Unknown
NCT02591901 2020-03-18
PReSuTINeB
Buckinghamshire Healthcare NHS Trust
Phase 2 Completed